Identification of and Structural Insights into Hit Compounds
Por um escritor misterioso
Descrição
Frontiers Application of Fragment-Based Drug Discovery to Versatile Targets
Cryo-EM structures of human GPR34 enable the identification of selective antagonists
Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns - Ina Rothenaigner, Kamyar Hadian, 2021
High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need - ScienceDirect
AI in Drug Discovery and Repurposing: Benefits, Approaches
In Silico Drug Design- Definition, Methods, Types, Uses
CDoT Drug Discovery Project Capabilities
Solutions for challenging targets with difficulty in hit identification - Axcelead Drug Discovery Partners, Inc.
Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases - ScienceDirect
Structure-based molecular modeling in SAR analysis and lead optimization - ScienceDirect
Frontiers In silico identification of potential inhibitors of acyl carrier protein reductase and acetyl CoA carboxylase of Plasmodium falciparum in antimalarial therapy
Fragment screening using biolayer interferometry reveals ligands targeting the SHP-motif binding site of the AAA+ ATPase p97
Combination of In Silico and In Vitro Screening to Identify Novel Glutamate Carboxypeptidase II Inhibitors
Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery
